New enlightenment of skin cancer chemoprevention through phytochemicals: In vitro and in vivo studies and the underlying mechanisms

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Singh, Madhulika ^a   Suman, Shankar ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CURCUMIN; DAIDZEIN; DAIDZIN; DIMETHYLBENZ[A]ANTHRACENE; GENISTEIN; GENISTIN; HYPOXIA INDUCIBLE FACTOR 1; LUPEOL; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT MEDICINAL PRODUCT; POLYCYCLIC AROMATIC HYDROCARBON; POLYPHENOL; POMEGRANATE EXTRACT; PROANTHOCYANIDIN; PROSTAGLANDIN SYNTHASE; RAS PROTEIN; RESVERATROL; SILYMARIN; STRESS ACTIVATED PROTEIN KINASE;

CAMELLIA SINENSIS; CELL METABOLISM; CELLULAR STRESS RESPONSE; CHEMOPROPHYLAXIS; DNA DAMAGE; GENE EXPRESSION; GINGER; GRAPE; HERPES VIRUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; POMEGRANATE; RADIATION EXPOSURE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; WART VIRUS; ANIMAL; BIOLOGICAL MODEL; PATHOPHYSIOLOGY; SKIN; SKIN NEOPLASMS;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; PHYTOCHEMICALS; SKIN; SKIN NEOPLASMS;

EID: 84897496761     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/243452     Document Type: Review

References (169)

1. Newell G. R., Sider J. G., Bergfelt L., Kripke M. L., Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Research 1988 48 17 5036 5041 2-s2.0-0023689015
2. American Cancer Society, Cancer Facts and Figures 2012. 2012, http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-031941.pdf
3. Jerant A. F., Johnson J. T., Sheridan C. D., Caffrey T. J., Early detection and treatment of skin cancer. American Family Physician 2000 62 2 357 382 2-s2.0-0034661340
4. Armstrong B. K., Kricker A., How much melanoma is caused by sun exposure. Melanoma Research 1993 3 6 395 401 2-s2.0-0027752348 (Pubitemid 24051362)
5. Tanos T., Marinissen M. J., Leskow F. C., Hochbaum D., Martinetto H., Gutkind J. S., Coso O. A., Phosphorylation of c-Fos by members of the p38 MAPK family: role in the AP-1 response to UV light. Journal of Biological Chemistry 2005 280 19 18842 18852 2-s2.0-21444439970 10.1074/jbc.M500620200 (Pubitemid 41379586)
6. Miller D. L., Weinstock M. A., Nonmelanoma skin cancer in the United States: incidence. Journal of the American Academy of Dermatology 1994 30 5 774 778 2-s2.0-0028284693 (Pubitemid 24157120)
7. Kligman L. H., Photoaging. Manifestations, prevention, and treatment. Dermatologic Clinics 1986 4 3 517 528 2-s2.0-0022752855
8. Mukhtar H., Elmets C. A., Photocarcinogenesis: mechanisms, models and human health implications. Photochemistry and Photobiology 1996 63 4 355 447 2-s2.0-0030114516
9. Chen A. C., Halliday G. M., Damian D. L., Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology 2013 45 3 331 341
10. Nichols J. A., Katiyar S. K., Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Archives of Dermatological Research 2010 302 2 71 83 2-s2.0-77449147298 10.1007/s00403-009-1001-3
11. Boffetta P., Jourenkova N., Gustavsson P., Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes and Control 1997 8 3 444 472 2-s2.0-0030872306 10.1023/A:1018465507029 (Pubitemid 27297808)
12. Millard L. G., Multiple pigmented papular basal cell carcinomas: a new pattern of industrial tar induced skin tumours. British Journal of Industrial Medicine 1986 43 2 134 136 2-s2.0-0022590369 (Pubitemid 16132575)
13. Surdu S., Fitzgerald E. F., Bloom M. S., Boscoe F. P., Carpenter D. O., Haase R. F., Gurzau E., Rudnai P., Koppova K., Févotte J., Vahter M., Leonardi G., Goessler W., Kumar R., Fletcher T., Occupational exposure to arsenic and risk of non-melanoma skin cancer in a multinational European study. International Journal of Cancer 2013 133 9 2182 2191 10.1002/ijc.28216
14. Molho-Pessach V., Lotem M., Viral carcinogenesis in skin cancer. Current Problems in Dermatology 2007 35 39 51 2-s2.0-34547510475 10.1159/0000106409
15. Filler R. B., Roberts S. J., Girardi M., Cutaneous two-stage chemical carcinogenesis. CSH Protocol 2007 2007 pdb.prot4837
16. Miyata M., Furukawa M., Takahashi K., Gonzalez F. J., Yamazoe Y., Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ. Japanese Journal of Pharmacology 2001 86 3 302 309 2-s2.0-0034897511 10.1254/jjp.86.302 (Pubitemid 32743225)
17. Pearson G., Robinson F., Gibson T. B., Xu B.-E., Karandikar M., Berman K., Cobb M. H., Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 2001 22 2 153 183 2-s2.0-0034997845 10.1210/er.22.2.153 (Pubitemid 32458157)
18. Cowan K. J., Storey K. B., Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. Journal of Experimental Biology 2003 206 7 1107 1115 2-s2.0-0037389558 10.1242/jeb.00220 (Pubitemid 36409152)
19. Cobb M. H., Goldsmith E. J., How MAP kinases are regulated. Journal of Biological Chemistry 1995 270 25 14843 14846 2-s2.0-0029043582 10.1074/jbc.270.25.14843
20. Rajagopalan H., Bardelli A., Lengauer C., Kinzler K. W., Vogelstein B., Velculescu V. E., RAF/RAS oncogenes and mismatch-repair status. Nature 2002 418 6901 934 2-s2.0-0037194728 10.1038/418934a (Pubitemid 34976022)
21. Djavaheri-Mergny M., Dubertret L., UV-A-induced AP-1 activation requires the Raf/ERK pathway in human NCTC 2544 keratinocytes. Experimental Dermatology 2001 10 3 204 210 2-s2.0-0035024784 10.1034/j.1600-0625.2001.010003204.x (Pubitemid 32492483)
22. Hoyos B., Imam A., Korichneva I., Levi E., Chua R., Hammerling U., Activation of c-Raf kinase by ultraviolet light: regulation by retinoids. Journal of Biological Chemistry 2002 277 26 23949 23957 2-s2.0-0037189575 10.1074/jbc.M110750200 (Pubitemid 34952240)
23. Verma I. M., Stevenson J. K., Schwarz E. M., van Antwerp D., Miyamoto S., Rel/NF- B/I B family: intimate tales of association and dissociation. Genes and Development 1995 9 22 2723 2735 2-s2.0-0028971289 (Pubitemid 3009952)
24. Zhang J. Y., Selim M. A., The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer. American Journal of Cancer Research 2012 2 6 691 698
25. Liu K., Yu D., Cho Y. Y., Bode A. M., Ma W., Yao K., Li S., Li J., Bowden G. T., Dong Z., Dong Z., Sunlight UV-induced skin cancer relies upon activation of the p38 α signaling pathway. Cancer Research 2013 73 7 2181 2188
26. Dickinson S. E., Olson E. R., Zhang J., Cooper S. J., Melton T., Criswell P. J., Casanova A., Dong Z., Hu C., Saboda K., Jacobs E. T., Alberts D. S., Bowden G. T., P38 MAP kinase plays a functional role in UVB-Induced mouse skin carcinogenesis. Molecular Carcinogenesis 2011 50 6 469 478 2-s2.0-79955733512 10.1002/mc.20734
27. Cantley L. C., The phosphoinositide 3-kinase pathway. Science 2002 296 5573 1655 1657 2-s2.0-0037205048 10.1126/science.296.5573.1655 (Pubitemid 34579158)
28. Wan Y. S., Wang Z. Q., Shao Y., Voorhees J. J., Fisher G. J., Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. International journal of oncology 2001 18 3 461 466 2-s2.0-0035289595
29. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S. M., Riggins G. J., Willson J. K. V., Markowitz S., Kinzler K. W., Vogelstein B., Velculescu V. E., High Frequency of Mutations of the PIK3CA Gene in Human Cancers. Science 2004 304 5670 554 2-s2.0-11144358645 10.1126/science.1096502 (Pubitemid 38541907)
30. Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenis J., Greenberg M. E., Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999 96 6 857 868 2-s2.0-0033582929 (Pubitemid 29165088)
31. Los M., Maddika S., Erb B., Schulze-Osthoff K., Switching akt: from survival signaling to deadly response. BioEssays 2009 31 5 492 495 2-s2.0-66449118214 10.1002/bies.200900005
32. Ozes O. N., Mayo L. D., Gustin J. A., Pfeffer S. R., Pfeffer L. M., Donner D. B., NF- B activation by tumour necrosis factor requires tie Akt serine-threonine kinase. Nature 1999 401 6748 82 85 2-s2.0-0033517189 10.1038/43466 (Pubitemid 29418447)
33. Castellano E., Downward J., Ras interaction with PI3K: more than just another effector pathway. Genes and Cancer 2011 2 3 261 274 2-s2.0-79960055459 10.1177/1947601911408079
34. Müller-Decker K., Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence. Cancer and Metastasis Reviews 2011 30 3-4 343 361 2-s2.0-83855162789 10.1007/s10555-011-9306-z
35. Rundhaug J. E., Mikulec C., Pavone A., Fischer S. M., A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis. Molecular Carcinogenesis 2007 46 8 692 698 2-s2.0-34547876147 10.1002/mc.20329 (Pubitemid 47255189)
36. Fischer S. M., Is cyclooxygenase-2 important in skin carcinogenesis? Journal of Environmental Pathology, Toxicology and Oncology 2002 21 2 183 191 (Pubitemid 34655039)
37. Giaccia A., Siim B. G., Johnson R. S., HIF-1 as a target for drug development. Nature Reviews Drug Discovery 2003 2 10 803 811 2-s2.0-0242331755 (Pubitemid 37361812)
38. Strieter R. M., Masters of angiogenesis. Nature Medicine 2005 11 9 925 927 2-s2.0-24744434146 10.1038/nm0905-925 (Pubitemid 41294434)
39. Cho Y.-S., Kim C.-H., Park J.-W., Involvement of HIF-1 α in UVB-induced epidermal hyperplasia. Molecules and Cells 2009 28 6 537 543 2-s2.0-76649106406 10.1007/s10059-009-0148-2
40. Li Y., Bi Z., Yan B., Wan Y., UVB radiation induces expression of HIF-1 α and VEGF through the EGFR/PI3K/DEC1 pathway. International Journal of Molecular Medicine 2006 18 4 713 719 2-s2.0-34248219509
41. Hertog M. G. L., Hollman P. C. H., Katan M. B., Kromhout D., Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutrition and Cancer 1993 20 1 21 29 2-s2.0-0027291905 (Pubitemid 23225364)
42. Mittal A., Elmets C. A., Katiyar S. K., Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 2003 24 8 1379 1388 2-s2.0-0042889220 10.1093/carcin/bgg095 (Pubitemid 37038827)
43. Meeran S. M., Vaid M., Punathil T., Katiyar S. K., Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis 2009 30 3 520 528 2-s2.0-62349122348 10.1093/carcin/bgp019
44. Nandakumar V., Singh T., Katiyar S. K., Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Letters 2008 269 2 378 387 2-s2.0-51549102594 10.1016/j.canlet.2008.03.049
45. Yamakoshi J., Saito M., Kataoka S., Kikuchi M., Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food and Chemical Toxicology 2002 40 5 599 607 2-s2.0-0036230511 10.1016/S0278-6915(02)00006-6 (Pubitemid 34310425)
46. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L., Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition 2004 79 5 727 747 (Pubitemid 41103873)
47. Zhao J., Wang J., Chen Y., Agarwal R., Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 1999 20 9 1737 1745 2-s2.0-0032821619 10.1093/carcin/20.9.1737 (Pubitemid 29410553)
48. Sharma S. D., Meeran S. M., Katiyar S. K., Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor- B signaling in in vivo SKH-1 hairless mice. Molecular Cancer Therapeutics 2007 6 3 995 1005 2-s2.0-34147118099 10.1158/1535-7163.MCT-06-0661 (Pubitemid 46554569)
49. Sharma S. D., Katiyar S. K., Dietary grape seed proanthocyanidins inhibit UVB-induced cyclooxygenase-2 expression and other inflammatory mediators in UVB-exposed skin and skin tumors of SKH-1 hairless mice. Pharmaceutical Research 2010 27 6 1092 1102 2-s2.0-77953233429 10.1007/s11095-010-0050-9
50. Vaid M., Singh T., Prasad R., Elmets C. A., Xu H., Katiyar S. K., Bioactive grape proanthocyanidins enhance immune reactivity in UV-irradiated skin through functional activation of dendritic cells in mice. Cancer Prevention Research 2013 6 3 242 252
51. Yuan X.-Y., Liu W., Hao J.-C., Gu W.-J., Zhao Y.-S., Topical grape seed proanthocyandin extract reduces sunburn cells and mutant p53 positive epidermal cell formation, and prevents depletion of langerhans cells in an acute sunburn model. Photomedicine and Laser Surgery 2012 30 1 20 25 2-s2.0-84855466016 10.1089/pho.2011.3043
52. Bomser J. A., Singletary K. W., Wallig M. A., Smith M. A. L., Inhibition of TPA-induced tumor promotion in CD-1 mouse epidermis by a polyphenolic fraction from grape seeds. Cancer Letters 1999 135 2 151 157 2-s2.0-0032991077 10.1016/S0304-3835(98)00289-4 (Pubitemid 29090327)
53. Bomser J., Singletary K., Meline B., Inhibition of 12-O- tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin ornithine decarboxylase and protein kinase C by polyphenolics from grapes. Chemico-Biological Interactions 2000 127 1 45 59 2-s2.0-0034659120 10.1016/S0009-2797(00)00170-8 (Pubitemid 30618731)
54. Mantena S. K., Katiyar S. K., Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF- B signaling in human epidermal keratinocytes. Free Radical Biology and Medicine 2006 40 9 1603 1614 2-s2.0-33747866718 10.1016/j.freeradbiomed.2005.12.032 (Pubitemid 44316663)
55. Meeran S. M., Katiyar S. K., Grape seed proanthocyanidins promote apoptosis in human epidermoid carcinoma A431 cells through alterations in Cdki-Cdk-cyclin cascade, and caspase-3 activation via loss of mitochondrial membrane potential. Experimental Dermatology 2007 16 5 405 415 2-s2.0-34247159678 10.1111/j.1600-0625.2007.00542.x (Pubitemid 46585368)
56. Vaid M., Singh T., Katiyar S. K., Grape seed Proanthocyanidins inhibit Melanoma cell invasiveness by reduction of PGE2 synthesis and reversal of Epithelial-to-Mesenchymal transition. PLoS ONE 2011 6 6 2-s2.0-79959620404 10.1371/journal.pone.0021539 e21539
57. Vaid M., Prasad R., Singh T., Jones V., Katiyar S. K., Grape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators. Toxicology and Applied Pharmacology 2012 263 1 122 130
58. Kim W., Yang J. H., Youn H., Yun Y. J., Seong K. M., Youn B., Myricetin inhibits Akt survival signaling and induces badmediated apoptosis in a low dose ultraviolet (UV)-B-irradiated hacat human immortalized keratinocytes. Journal of Radiation Research 2010 51 3 285 296
59. Jung S. K., Lee K. W., Byun S., Kang N. J., Lim S. H., Heo Y.-S., Bode A. M., Bowden G. T., Lee H. J., Dong Z., Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Research 2008 68 14 6021 6029 2-s2.0-48649090159 10.1158/0008-5472.CAN-08-0899
60. Kang N. J., Lee K. W., Shin B. J., Jung S. K., Hwang M. K., Bode A. M., Heo Y.-S., Lee H. J., Dong Z., Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis 2009 30 2 321 330 2-s2.0-60149095366 10.1093/carcin/bgn282
61. Arasada B. L., Bommareddy A., Zhang X., Bremmon K., Dwivedi C., Effects of α -santalol on proapoptotic caspases and p53 expression in UVB irradiated mouse skin. Anticancer Research 2008 28 1 129 132 2-s2.0-40549139093 (Pubitemid 351362891)
62. Surjana D., Halliday G. M., Damian D. L., Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin. Carcinogenesis 2013 34 5 1144 1149
63. Li J., Malakhova M., Mottamal M., Reddy K., Kurinov I., Carper A., Langfald A., Oi N., Kim M. O., Zhu F., Sosa C. P., Zhou K., Bode A. M., Dong Z., Norathyriol suppresses skin cancers induced by solar ultraviolet radiation by targeting ERK kinases. Cancer Research 2012 72 1 260 270 2-s2.0-84855361776 10.1158/0008-5472.CAN-11-2596
64. Bettoli V., Zauli S., Virgili A., Retinoids in the chemoprevention of non-elanoma skin cancers: why, when and how. Journal of Dermatological Treatment 2013 24 3 235 237
65. Li W., Liu J., Zhao Y., PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells. Molecular Carcinogenesis 2012 10.1002/mc.21988
66. Staniforth V., Huang W.-C., Aravindaram K., Yang N.-S., Ferulic acid, a phenolic phytochemical, inhibits UVB-induced matrix metalloproteinases in mouse skin via posttranslational mechanisms. Journal of Nutritional Biochemistry 2012 23 5 443 451 2-s2.0-84859822439 10.1016/j.jnutbio.2011.01.009
67. Vaid M., Sharma S. D., Katiyar S. K., Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. Carcinogenesis 2010 31 11 2004 2011 2-s2.0-78149234280 10.1093/carcin/bgq186
68. Sime S., Reeve V. E., Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical pycnogenol B7. Photochemistry and Photobiology 2004 79 2 193 198
69. Sarfaraz S., Siddiqui I. A., Syed D. N., Afaq F., Mukhtar H., Guggulsterone modulates MAPK and NF- B pathways and inhibits skin tumorigenesis in SENCAR mice. Carcinogenesis 2008 29 10 2011 2018 2-s2.0-53349108487 10.1093/carcin/bgn180
70. Lee J.-C., Kundu J. K., Hwang D.-M., Na H.-K., Surh Y.-J., Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF- B and AP-1: I B kinase and c-Jun-N-terminal kinase as respective potential upstream targets. Carcinogenesis 2007 28 7 1491 1498 2-s2.0-34547838415 10.1093/carcin/bgm054 (Pubitemid 47243539)
71. Byun S., Park J., Lee E., Lim S., Yu J. G., Lee S. J., Chen H., Dong Z., Lee K. W., Lee H. J., Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis 2013 34 2 397 405
72. Lai C.-S., Li S., Chai C.-Y., Lo C.-Y., Ho C.-T., Wang Y.-J., Pan M.-H., Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3′4′- hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis 2007 28 12 2581 2588 2-s2.0-36949006565 10.1093/carcin/bgm231 (Pubitemid 350238961)
73. Kim J., Park H., Kim J., Park J. H. Y., 3,3′-Diindolylmethane suppresses 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and tumor promotion in mouse skin via the downregulation of inflammatory mediators. Molecular Carcinogenesis 2010 49 7 672 683
74. Chung W. Y., Park J. H., Kim M. J., Kim H. O., Hwang J. K., Lee S. K., Park K. K., Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor- B. Carcinogenesis 2007 28 6 1224 1231 2-s2.0-34447532263 10.1093/carcin/bgm005 (Pubitemid 47064310)
75. Afaq F., Saleem M., Aziz M. H., Mukhtar H., Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin. Toxicology and Applied Pharmacology 2004 195 3 361 369 2-s2.0-1542407656 10.1016/j.taap.2003.09.027 (Pubitemid 38338657)
76. Afaq F., Syed D. N., Malik A., Hadi N., Sarfaraz S., Kweon M.-H., Khan N., Zaid M. A., Mukhtar H., Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis. Journal of Investigative Dermatology 2007 127 1 222 232 2-s2.0-33845744294 10.1038/sj.jid.5700510 (Pubitemid 46005682)
77. Decker E. A., Phenolics: prooxidants or antioxidants? Nutrition Reviews 1997 55 11 396 398 2-s2.0-0031439712 (Pubitemid 28026338)
78. Jain A., Manghani C., Kohli S., Nigam D., Rani V., Tea and human health: the dark shadows. Toxicology Letters 2013 220 1 82 87 10.1016/j.toxlet.2013.04. 010
79. Wang Z. Y., Agarwal R., Bickers D. R., Mukhtar H., Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 1991 12 8 1527 1530 2-s2.0-0025834628
80. Agarwal R., Katiyar S. K., Khan S. G., Mukhtar H., Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea. Photochemistry and Photobiology 1993 58 5 695 700 2-s2.0-0027692047 (Pubitemid 2028260)
81. Katiyar S. K., Vaid M., van Steeg H., Meeran S. M., Green tea polyphenols prevent uv-induced immunosuppression by rapid repair of DNA damage and enhancement of nucleotide excision repair genes. Cancer Prevention Research 2010 3 2 179 189 2-s2.0-77949702385 10.1158/1940-6207.CAPR-09-0044
82. Meeran S. M., Akhtar S., Katiyar S. K., Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. Journal of Investigative Dermatology 2009 129 5 1258 1270 2-s2.0-65049090554 10.1038/jid.2008.354
83. Afaq F., Ahmad N., Mukhtar H., Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 2003 22 58 9254 9264 2-s2.0-1642540094 10.1038/sj.onc.1207035 (Pubitemid 38122037)
84. Katiyar S. K., Challa A., McCormick T. S., Cooper K. D., Mukhtar H., Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 1999 20 11 2117 2124 2-s2.0-0032740780 10.1093/carcin/20.11.2117 (Pubitemid 29535313)
85. Meeran S. M., Mantena S. K., Katiyar S. K., Prevention of ultraviolet radiation-induced immunosuppression by (-)-epigallocatechin-3-gallate in mice is mediated through interleukin 12-dependent DNA repair. Clinical Cancer Research 2006 12 7, part 1 2272 2280 2-s2.0-33646247004 10.1158/1078-0432.CCR-05-2672
86. Meeran S. M., Mantena S. K., Elmets C. A., Katiyar S. K., (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Research 2006 66 10 5512 5520 2-s2.0-33744943796 10.1158/0008-5472.CAN-06-0218 (Pubitemid 43844980)
87. Katiyar S. K., Mukhtar H., Green tea polyphenol (-)-epigallocatechin-3- gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. Journal of Leukocyte Biology 2001 69 5 719 726 2-s2.0-0035011985 (Pubitemid 32466409)
88. Vayalil P. K., Elments C. A., Katiyar S. K., Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 2003 24 5 927 936 2-s2.0-0037972228 10.1093/carcin/bgg025 (Pubitemid 36748910)
89. Katiyar S. K., Mukhtar H., Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols. Carcinogenesis 1997 18 10 1911 1916 2-s2.0-0031426307 10.1093/carcin/18.10.1911 (Pubitemid 28132374)
90. Patel R., Krishnan R., Ramchandani A., Maru G., Polymeric black tea polyphenols inhibit mouse skin chemical carcinogenesis by decreasing cell proliferation. Cell Proliferation 2008 41 3 532 553 2-s2.0-43749106622 10.1111/j.1365-2184.2008.00528.x (Pubitemid 351692944)
91. Kumar G., Dange P., Kailaje V., Vaidya M. M., Ramchandani A. G., Maru G. B., Polymeric black tea polyphenols modulate the localization and activity of 12-O-tetradecanoylphorbol-13-acetate-mediated kinases in mouse skin: mechanisms of their anti-tumor-promoting action. Free Radical Biology & Medicine 2012 53 6 1358 1370
92. Katiyar S. K., Afaq F., Azizuddin K., Mukhtar H., Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicology and Applied Pharmacology 2001 176 2 110 117 2-s2.0-0034756194 10.1006/taap.2001.9276 (Pubitemid 33015861)
93. Afaq F., Adhami V. M., Ahmad N., Mukhtar H., Inhibition of ultraviolet B-mediated activation of nuclear factor B in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene 2003 22 7 1035 1044 2-s2.0-0037455718 10.1038/sj.onc.1206206 (Pubitemid 36313147)
94. Ahmad N., Gupta S., Mukhtar H., Green tea polyphenol epigallocatechin-3- gallate differentially modulates nuclear factor B in cancer cells versus normal cells. Archives of Biochemistry and Biophysics 2000 376 2 338 346 2-s2.0-0034655603 10.1006/abbi.2000.1742 (Pubitemid 30210882)
95. Balasubramanian S., Adhikary G., Eckert R. L., The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis 2010 31 3 496 503 2-s2.0-77950907191 10.1093/carcin/bgp314
96. Choudhury S. R., Balasubramanian S., Chew Y. C., Han B., Marquez V. E., Eckert R. L., (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. Carcinogenesis 2011 32 10 1525 1532 2-s2.0-80053139713 10.1093/carcin/bgr171
97. Bickers D. R., Athar M., Novel approaches to chemoprevention of skin cancer. Journal of Dermatology 2000 27 11 691 695 2-s2.0-0034535518 (Pubitemid 32015640)
98. Hakim I. A., Harris R. B., Weisgerber U. M., Tea intake and squamous cell carcinoma of the skin: influence of type of tea beverages. Cancer Epidemiology Biomarkers and Prevention 2000 9 7 727 731 2-s2.0-0033928082 (Pubitemid 30482705)
99. Katiyar S. K., Perez A., Mukhtar H., Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Clinical Cancer Research 2000 6 10 3864 3869 2-s2.0-0033755116
100. Jurenka J. S., Therapeutic applications of pomegranate (Punica granatum L.): a review. Alternative Medicine Review 2008 13 2 128 144 2-s2.0-47549111139
101. Park H. M., Moon E., Kim A.-J., Kim M. H., Lee S., Lee J. B., Park Y. K., Jung H.-S., Kim Y.-B., Kim S. Y., Extract of Punica granatum inhibits skin photoaging induced by UVB irradiation. International Journal of Dermatology 2010 49 3 276 282 2-s2.0-77949889786 10.1111/j.1365-4632.2009.04269.x
102. Adhami V. M., Khan N., Mukhtar H., Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutrition and Cancer 2009 61 6 811 815 2-s2.0-77952537236 10.1080/01635580903285064
103. Afaq F., Saleem M., Krueger C. G., Reed J. D., Mukhtar H., Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF- B pathways and inhibits skin tumorigenesis in CD-1 mice. International Journal of Cancer 2005 113 3 423 433 2-s2.0-11144335895 10.1002/ijc.20587 (Pubitemid 40038710)
104. Hora J. J., Maydew E. R., Lansky E. P., Dwivedi C., Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. Journal of Medicinal Food 2003 6 3 157 161 2-s2.0-0344845219 (Pubitemid 37445026)
105. Afaq F., Khan N., Syed D. N., Mukhtar H., Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Photochemistry and Photobiology 2010 86 6 1318 1326 2-s2.0-78649663233 10.1111/j.1751-1097.2010.00815.x
106. Khan N., Syed D. N., Pal H. C., Mukhtar H., Afaq F., Pomegranate fruit extract inhibits UVB-induced inflammation and proliferation by modulating NF- κ B and MAPK signaling pathways in mouse skin. Photochemistry and Photobiology 2012 88 5 1126 1134 10.1111/j.1751-1097.2011.01063.x
107. Afaq F., Malik A., Syed D., Maes D., Matsui M. S., Mukhtar H., Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes. Photochemistry and Photobiology 2005 81 1 38 45 2-s2.0-14744277141 10.1562/2004-08-06-RA-264.1 (Pubitemid 40327558)
108. Syed D. N., Malik A., Hadi N., Sarfaraz S., Afaq F., Mukhtar H., Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes. Photochemistry and Photobiology 2006 82 2 398 405 2-s2.0-33646268191 10.1562/2005-06-23-RA-589
109. Zaid M. A., Afaq F., Syed D. N., Dreher M., Mukhtar H., Inhibition of UVB-mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx. Photochemistry and Photobiology 2007 83 4 882 888 2-s2.0-34447641229 10.1111/j.1751-1097.2007. 00157.x (Pubitemid 47087402)
110. Pacheco-Palencia L. A., Noratto G., Hingorani L., Talcott S. T., Mertens-Talcott S. U., Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. Journal of Agricultural and Food Chemistry 2008 56 18 8434 8441 2-s2.0-53649096676 10.1021/jf8005307
111. Afaq F., Zaid M. A., Khan N., Dreher M., Mukhtar H., Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin. Experimental Dermatology 2009 18 6 553 561 2-s2.0-66149142794 10.1111/j.1600-0625.2008.00829.x
112. Kasai K., Yoshimura M., Koga T., Arii M., Kawasaki S., Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. Journal of Nutritional Science and Vitaminology 2006 52 5 383 388 2-s2.0-33846035455 10.3177/jnsv.52.383 (Pubitemid 46065556)
113. Afaq F., Adhami V. M., Ahmad N., Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicology and Applied Pharmacology 2003 186 1 28 37 2-s2.0-0037288709 10.1016/S0041-008X(02) 00014-5 (Pubitemid 36262946)
114. Jang M., Cai L., Udeani G. O., Slowing K. V., Thomas C. F., Beecher C. W. W., Fong H. H. S., Farnsworth N. R., Kinghorn A. D., Mehta R. G., Moon R. C., Pezzuto J. M., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997 275 5297 218 220 2-s2.0-0031561513 (Pubitemid 127696281)
115. Soleas G. J., Grass L., Josephy P. D., Goldberg D. M., Diamandis E. P., A comparison of the anticarcinogenic properties of four red wine polyphenols. Clinical Biochemistry 2002 35 2 119 124 2-s2.0-0036230973 10.1016/S0009-9120(02) 00275-8 (Pubitemid 34442691)
116. Kapadia G. J., Azuine M. A., Tokuda H., Takasaki M., Mukainaka T., Konoshima T., Nishino H., Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacological Research 2002 45 6 499 505 2-s2.0-0036425598 10.1006/phrs.2002.0992 (Pubitemid 35304500)
117. Fu Z.-D., Cao Y., Wang K.-F., Xu S.-F., Han R., Chemopreventive effect of resveratrol to cancer. Chinese Journal of Cancer 2004 23 8 869 873 2-s2.0-16644373850
118. Reagan-Shaw S., Afaq F., Aziz M. H., Ahmad N., Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 2004 23 30 5151 5160 2-s2.0-3142678185 10.1038/sj.onc.1207666 (Pubitemid 38980348)
119. Aziz M. H., Afaq F., Ahmad N., Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochemistry and Photobiology 2005 81 1 25 31 2-s2.0-14744268831 10.1562/2004-08-13-RA-274.1 (Pubitemid 40327556)
120. Kalra N., Roy P., Prasad S., Shukla Y., Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sciences 2008 82 7-8 348 358 2-s2.0-39149132456 10.1016/j.lfs.2007.11.006
121. Kundu J. K., Shin Y. K., Kim S. H., Surh Y.-J., Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF- B in mouse skin by blocking I B kinase activity. Carcinogenesis 2006 27 7 1465 1474 2-s2.0-33745728903 10.1093/carcin/bgi349 (Pubitemid 43994860)
122. Roy P., Kalra N., Prasad S., George J., Shukla Y., Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharmaceutical Research 2009 26 1 211 217 2-s2.0-57749170979 10.1007/s11095-008-9723-z
123. Yusuf N., Nasti T. H., Meleth S., Elmets C. A., Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Molecular Carcinogenesis 2009 48 8 713 723 2-s2.0-68849113447 10.1002/mc.20517
124. Kowalczyk M. C., Kowalczyk P., Tolstykh O., Hanausek M., Walaszek Z., Slaga T. J., Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice. Cancer Prevention Research 2010 3 2 170 178 2-s2.0-77949721987 10.1158/1940-6207.CAPR-09-0196
125. Adhami V. M., Afaq F., Ahmad N., Suppression of ultraviolet B exposure-mediated activation of NF- B in normal human keratinocytes by resveratrol. Neoplasia 2003 5 1 74 82 2-s2.0-0037251437 (Pubitemid 36151060)
126. Adhami V. M., Afaq F., Ahmad N., Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochemical and Biophysical Research Communications 2001 288 3 579 585 2-s2.0-0035798154 10.1006/bbrc.2001.5819 (Pubitemid 33030069)
127. Ahmad N., Adhami V. M., Afaq F., Feyes D. K., Mukhtar H., Resveratrol causes WAF-1/p21-mediated G1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clinical Cancer Research 2001 7 5 1466 1473 2-s2.0-0034902229 (Pubitemid 32708704)
128. Kim A. L., Zhu Y., Zhu H., Han L., Kopelovich L., Bickers D. R., Athar M., Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. Experimental Dermatology 2006 15 7 538 546 2-s2.0-33744831517 10.1111/j.1600-0625.2006.00445.x (Pubitemid 43834489)
129. Kim K. H., Back J. H., Zhu Y., Arbesman J., Athar M., Kopelovich L., Kim A. L., Bickers D. R., Resveratrol targets transforming growth factor- Β 2 signaling to block UV-induced tumor progression. Journal of Investigative Dermatology 2011 131 1 195 202 2-s2.0-78650302198 10.1038/jid.2010.250
130. Hao Y., Huang W., Liao M., Zhu Y., Liu H., Hao C., Liu G., Zhang G., Feng H., Ning X., Li H., Li Z., The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice. Fitoterapia 2013 86 84 91
131. Bastianetto S., Dumont Y., Duranton A., Vercauteren F., Breton L., Quirion R., Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. PLoS ONE 2010 5 9 2-s2.0-77958531915 10.1371/journal.pone.0012935 e12935
132. Cottart C.-H., Nivet-Antoine V., Laguillier-Morizot C., Beaudeux J.-L., Resveratrol bioavailability and toxicity in humans. Molecular Nutrition and Food Research 2010 54 1 7 16 2-s2.0-74349100733 10.1002/mnfr.200900437
133. Tsai M. L., Lai C. S., Chang Y. H., Chen W. J., Ho C. T., Pan M. H., Pterostilbene, a natural analogue of resveratrol, potently inhibits 7, 12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis. Food & Function 2012 3 11 1185 1194
134. Rajamanickam S., Velmurugan B., Kaur M., Singh R. P., Agarwal R., Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Research 2010 70 6 2368 2378 2-s2.0-77950255061 10.1158/0008-5472.CAN-09- 3249
135. Lahiri-Chatterjee M., Katiyar S. K., Mohan R. R., Agarwal R., A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Research 1999 59 3 622 632 2-s2.0-0033082440 (Pubitemid 29076060)
136. Singh R. P., Tyagi A. K., Zhao J., Agarwal R., Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis 2002 23 3 499 510 2-s2.0-0036210452 (Pubitemid 34257631)
137. Katiyar S. K., Korman N. J., Mukhtar H., Agarwal R., Protective effects of silymarin against photocarcinogenesis in a mouse skin model. Journal of the National Cancer Institute 1997 89 8 556 566 2-s2.0-0030903321 (Pubitemid 27172945)
138. Gu M., Dhanalakshmi S., Singh R. P., Agarwal R., Dietary feeding of silibinin prevents early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Cancer Epidemiology Biomarkers and Prevention 2005 14 5 1344 1349 2-s2.0-18544383613 10.1158/1055-9965.EPI-04-0664 (Pubitemid 40656496)
139. Mallikarjuna G., Dhanalakshmi S., Singh R. P., Agarwal C., Agarwal R., Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Research 2004 64 17 6349 6356 2-s2.0-4344639798 10.1158/0008-5472.CAN-04-1632 (Pubitemid 39129441)
140. Dhanalakshmi S., Mallikarjuna G. U., Singh R. P., Agarwal R., Silibinin prevents ultraviolent radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. Carcinogenesis 2004 25 8 1459 1465 2-s2.0-4344650392 10.1093/carcin/bgh152 (Pubitemid 39162712)
141. Katiyar S. K., Meleth S., Sharma S. D., Silymarin, a flavonoid from milk thistle (Silybum marianum L.), inhibits UV-induced oxidative stress through targeting infiltrating CD11b+ cells in mouse skin. Photochemistry and Photobiology 2008 84 2 266 271 2-s2.0-41049114858 10.1111/j.1751-1097.2007. 00241.x (Pubitemid 351421379)
142. Wang Q., Liu W., Zeng H., Xie X., Zang G., Ye Y., Tashiro S., Onodera S., Jiang S., Ikejima T., p53-mediated autophagy adjustment is involved in the protection of silibinin against murine dermal inflammation and epidermal apoptosis induced by UVB irradiation. Journal of Asian Natural Products Research 2013 15 2 117 129
143. Wang Q., Ye Y., Liu W., Jiang S., Tashiro S., Onodera S., Gu F., Wang Y., Ikejima T., Dual effects of silibinin treatment on autophagy-regulated dermal apoptosis retardation and epidermal apoptosis up-regulation in UVB-induced skin inflammation. Journal of Asian Natural Products Research 2012 14 7 688 699
144. Li L.-H., Wu L.-J., Tashiro S.-I., Onodera S., Uchiumi F., Ikejima T., Silibinin prevents UV-induced HaCaT cell apoptosis partly through inhibition of caspase-8 pathway. Biological and Pharmaceutical Bulletin 2006 29 6 1096 1101 2-s2.0-33744946532 10.1248/bpb.29.1096 (Pubitemid 43845466)
145. Roy S., Deep G., Agarwal C., Agarwal R., Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45 α -dependent manner. Carcinogenesis 2012 33 3 629 636 2-s2.0-84857973987 10.1093/carcin/bgr299
146. Svobodová A., Zdarilová A., Malisková J., Mikulková H., Walterová D., Vostalová J., Attenuation of UVA-induced damage to human keratinocytes by silymarin. Journal of Dermatological Science 2007 46 1 21 30 (Pubitemid 46366634)
147. Narayanapillai S., Agarwal C., Tilley C., Agarwal R., Silibinin is a potent sensitizer of UVA radiation-induced oxidative stress and apoptosis in human keratinocyte haCaT cells. Photochemistry and Photobiology 2012 88 5 1135 1140 2-s2.0-84855472908 10.1111/j.1751-1097.2011.01050.x
148. Nigam N., Prasad S., Shukla Y., Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin. Food and Chemical Toxicology 2007 45 11 2331 2335 2-s2.0-34548822395 10.1016/j.fct.2007.06.002 (Pubitemid 47451582)
149. Saleem M., Afaq F., Adhami V. M., Mukhtar H., Lupeol modulates NF- B and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004 23 30 5203 5214 2-s2.0-3142676732 10.1038/sj.onc.1207641 (Pubitemid 38980353)
150. Nigam N., Prasad S., George J., Shukla Y., Lupeol induces p53 and cyclin-B-mediated G2/M arrest and targets apoptosis through activation of caspase in mouse skin. Biochemical and Biophysical Research Communications 2009 381 2 253 258 2-s2.0-61849102896 10.1016/j.bbrc.2009.02.033
151. Prasad S., Madan E., Nigam N., Roy P., George J., Shukla Y., Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NF B signaling pathways. Cancer Biology and Therapy 2009 8 17 1632 1639 2-s2.0-70350317603 10.4161/cbt.8.17.9204
152. Ishizaki C., Oguro T., Yoshida T., Wen C. Q., Sueki H., Iijima M., Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-o-tetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dermatology 1996 193 4 311 317 2-s2.0-0030459109 (Pubitemid 27007574)
153. Oguro T., Yoshida T., Effect of ultraviolet A on ornithine decarboxylase and metallothionein gene expression in mouse skin. Photodermatology Photoimmunology and Photomedicine 2001 17 2 71 78 2-s2.0-0035064895 10.1034/j.1600-0781.2001.017002071.x (Pubitemid 32280062)
154. Phillips J. M., Clark C., Herman-Ferdinandez L., Moore-Medlin T., Rong X., Gill J. R., Clifford J. L., Abreo F., Nathan C. O., Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo. International Journal of Dermatology 2010 49 6 608 622
155. Chan W.-H., Wu C.-C., Yu J.-S., Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. Journal of Cellular Biochemistry 2003 90 2 327 338 2-s2.0-0141529729 10.1002/jcb.10638 (Pubitemid 37222201)
156. Cho J.-W., Park K., Kweon G. R., Jang B.-C., Baek W.-K., Suh M.-H., Kim C.-W., Lee K.-S., Suh S.-I., Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Experimental and Molecular Medicine 2005 37 3 186 192 2-s2.0-22244486007 (Pubitemid 40992733)
157. Chen A.-L., Hsu C.-H., Lin J.-K., Hsu M.-M., Ho Y.-F., She T.-S., Ko J.-Y., Lin J.-T., Lin B.-R., Wu M.-S., Yu H.-S., Jee S.-H., Chen G.-S., Chen T.-M., Chen C.-A., Lai M.-K., Pu Y.-S., Pan M.-H., Wang Y.-J., Tsai C.-C., Hsieh C.-Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 2001 21 4 2895 2900 2-s2.0-0035174504 (Pubitemid 33051148)
158. Kim J.-K., Kim Y., Na K.-M., Surh Y.-J., Kim T.-Y., [6]-gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radical Research 2007 41 5 603 614 2-s2.0-34047135039 10.1080/10715760701209896 (Pubitemid 46511125)
159. Bode A. M., Dong Z., Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncology 2000 1 3 181 188 2-s2.0-0034334115
160. Wei H., Bowen R., Zhang X., Lebwohl M., Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis 1998 19 8 1509 1514 2-s2.0-0031686175 10.1093/carcin/19.8.1509 (Pubitemid 28409852)
161. Wei H., Zhang X., Wang Y., Lebwohl M., Inh olet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Letters 2002 185 1 21 29 2-s2.0-0037044562 10.1016/S0304-3835(02)00240-9 (Pubitemid 34876529)
162. Shyong E. Q., Lu Y., Lazinsky A., Saladi R. N., Phelps R. G., Austin L. M., Lebwohl M., Wei H., Effects of the isoflavone 4′5,7,- trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage. Carcinogenesis 2002 23 2 317 321 2-s2.0-0036125877 (Pubitemid 34224009)
163. Khan A. Q., Khan R., Rehman M. U., Lateef A., Tahir M., Ali F., Sultana S., Soy isoflavones (daidzein & genistein) inhibit 1-O-tetradecanoylphorbol- 13-acetate (TPA)-induced cutaneous inflammation via modulation of COX-2 and NF- B in Swiss albino mice. Toxicology 2012 302 2-3 2266 2274
164. Moore J. O., Wang Y., Stebbins W. G., Gao D., Zhou X., Phelps R., Lebwohl M., Wei H., Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesis. Carcinogenesis 2006 27 8 1627 1635 2-s2.0-33746581933 10.1093/carcin/bgi367 (Pubitemid 44288052)
165. Arora A., Siddiqui I. A., Shukla Y., Modulation of p53 in 7,12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice. Molecular Cancer Therapeutics 2004 3 11 1459 1466 2-s2.0-9444241651 (Pubitemid 39562591)
166. Arora A., Kalra N., Shukla Y., Regulation of p21/ras protein expression by diallyl sulfide in DMBA induced neoplastic changes in mouse skin. Cancer Letters 2006 242 1 28 36 2-s2.0-33749241471 10.1016/j.canlet.2005.10.049 (Pubitemid 44485292)
167. Kalra N., Arora A., Shukla Y., Involvement of multiple signaling pathways in diallyl sulfide mediated apoptosis in mouse skin tumors. Asian Pacific Journal of Cancer Prevention 2006 7 4 556 562 2-s2.0-33947517318
168. Khan A., Shukla Y., Kalra N., Alam M., Ahmad M. G., Hakim S. R., Owais M., Potential of diallyl sulfide bearing pH-sensitive liposomes in chemoprevention against DMBA-induced skin papilloma. Molecular Medicine 2007 13 7-8 443 451 2-s2.0-34548496058 10.2119/2006-00111.Khan (Pubitemid 47378146)
169. Nigam N., Shukla Y., Preventive effects of diallyl sulfide on 7,12-dimethylbenz[a]anthracene induced DNA alkylation damage in mouse skin. Molecular Nutrition and Food Research 2007 51 11 1324 1328 2-s2.0-36649010400 10.1002/mnfr.200700140 (Pubitemid 350195605)